Search - tctmd.com

Displaying 41 - 60 of 118

Sort: Relevancy | Date

Presentation TCT 2023

Five-Year Clinical and Echocardiographic Outcomes From The PARTNER 3 Low-Risk Randomized Trial

Presenter: Martin Leon

October 24, 2023

Presentation TCT 2023

Call to Action: Recommendations for Strengthening the Partnership Between Patients and Clinicians

Presenter: Susan Strong

October 23, 2023

Presentation TVT 2023

Bioprosthetic Surgical Valves in Intermediate-risk Patients: 1-Year Outcomes of the PARTNER 3 Mitral Valve-in-Valve Study

Presenter: Mayra Guerrero

June 10, 2023

Presentation TVT 2023

Case Presentation 3: Favoring TAVR Explant: When to Throw in the Towel and Operate

Presenter: Keith Allen

June 10, 2023

Presentation TCT 2021

PARTNER 3: Two-Year Economic Outcomes From a Randomized Trial of TAVR vs. SAVR in Patients at Low Surgical Risk

Presenter: David Cohen

November 05, 2021

Presentation TVT 2021

The PARTNER 3 Bicuspid Registry for SAPIEN 3 Transcatheter Aortic Valve Replacement in Patients at Low Surgical Risk

Presenter: Mathew Williams

July 20, 2021

Presentation TCT 2020

TAVR in Low Surgical Risk Patients - Evidence Updates From PARTNER 3

Presenter: Martin Leon

October 16, 2020

Presentation TVT 2020

SAPIEN 3 Transcatheter Aortic Valve Replacement Compared with Surgery in Intermediate-risk Patients: A Propensity-Matched Analysis of 5-year Outcomes

Presenter: Susheel K. Kodali

June 21, 2020

Presentation Cardiovascular Interventions 2019

Show me the Data: Key Clinical Trials of 2019

Presenter: Ehtisham Mahmud

November 01, 2019

Presentation TCT 2019

PARTNER 3: Health Status Outcomes From a Randomized Trial of Transcatheter vs. Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Low Surgical Risk

Presenter: Suzanne Baron

September 29, 2019

Presentation TCT 2019

PARTNER 2A: 5-Year Outcomes From a Randomized Trial of Transcatheter vs. Surgical Aortic Valve Replacement in Intermediate-Risk Patients With Severe Aortic Stenosis

Presenter: Vinod Thourani

September 28, 2019

Presentation TCT 2019

PARTNER 3 Low-Risk Computed Tomography Substudy: Subclinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Valves

Presenter: Raj Makkar

September 27, 2019

Presentation TCT 2019

Deep-Dive: NEW Insights From the PARTNER 3 Trial

Presenter: Martin Leon

September 26, 2019

Presentation TCT 2019

Complex CLI Case Review 3: What Is Possible in the OBL?

Presenter: Eric Dippel

September 25, 2019

Presentation TCT 2019

Clinical Trial Updates: BEST-CLI, BASIL-2 and BASIL-3

Presenter: Matthew Menard

September 25, 2019

Presentation TCT 2019

CTO Crossing 3: Case Examples of Antegrade Access and Closure

Presenter: Craig Walker

September 25, 2019

Presentation TVT 2019

Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: The PARTNER 3 Trial

Presenter: Philippe Pibarot

June 14, 2019

Presentation TVT 2019

Comparing the Low-Risk Trials (PARTNER 3 and Medtronic Low-Risk)

Presenter: Martin Leon

June 13, 2019

Presentation TVT 2019

Highlights From the PARTNER 3 Low-Risk Trial

Presenter: Michael Mack

June 13, 2019

Presentation TVT 2019

The PARTNER 3 Low-Risk Randomized Trial

Presenter: Susheel Kodali

June 13, 2019

Advertisement

Five-Year Clinical and Echocardiographic Outcomes From The PARTNER 3 Low-Risk Randomized Trial

Call to Action: Recommendations for Strengthening the Partnership Between Patients and Clinicians

Bioprosthetic Surgical Valves in Intermediate-risk Patients: 1-Year Outcomes of the PARTNER 3 Mitral Valve-in-Valve Study

Case Presentation 3: Favoring TAVR Explant: When to Throw in the Towel and Operate

PARTNER 3: Two-Year Economic Outcomes From a Randomized Trial of TAVR vs. SAVR in Patients at Low Surgical Risk

The PARTNER 3 Bicuspid Registry for SAPIEN 3 Transcatheter Aortic Valve Replacement in Patients at Low Surgical Risk

TAVR in Low Surgical Risk Patients - Evidence Updates From PARTNER 3

SAPIEN 3 Transcatheter Aortic Valve Replacement Compared with Surgery in Intermediate-risk Patients: A Propensity-Matched Analysis of 5-year Outcomes

Show me the Data: Key Clinical Trials of 2019

PARTNER 3: Health Status Outcomes From a Randomized Trial of Transcatheter vs. Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Low Surgical Risk

PARTNER 2A: 5-Year Outcomes From a Randomized Trial of Transcatheter vs. Surgical Aortic Valve Replacement in Intermediate-Risk Patients With Severe Aortic Stenosis

PARTNER 3 Low-Risk Computed Tomography Substudy: Subclinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Valves

Deep-Dive: NEW Insights From the PARTNER 3 Trial

Complex CLI Case Review 3: What Is Possible in the OBL?

Clinical Trial Updates: BEST-CLI, BASIL-2 and BASIL-3

CTO Crossing 3: Case Examples of Antegrade Access and Closure

Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: The PARTNER 3 Trial

Comparing the Low-Risk Trials (PARTNER 3 and Medtronic Low-Risk)

Highlights From the PARTNER 3 Low-Risk Trial

The PARTNER 3 Low-Risk Randomized Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content